Karuna Therapeutics, Inc. | TalkMarkets

Latest Posts

About This Stock More About This Stock

Bullish Continuation In '24? 3 Market Areas To Watch

Article By: Zacks Investment Research

Wednesday, January 10, 2024 11:00 PM EDT

This article discusses 3 market areas that should outperform dramatically over the next 12 months...

In this article: BMY, NVO, NVS, CYTK, IBB, MSFT, NVDA, IWM, META, GOOGL, KRTX

Read

Bristol-Myers Buying Karuna Signals A Biotech Boom Ahead: Jefferies

Article By: Invezz

Sunday, December 24, 2023 3:43 PM EDT

Bristol-Myers Squibb is buying Karuna Therapeutics for $14 billion. Karuna Therapeutics Inc stock jumped nearly 50% on Friday. Jefferies analyst Michael Yee shares his view on biotech stocks.

In this article: BMY, KRTX

Read

Bristol-Myers To Buy Karuna Therapeutics For $14B

Article By: Zacks Investment Research

Friday, December 22, 2023 11:11 AM EDT

Bristol-Myers Squibb announced that it will acquire the biopharmaceutical company Karuna Therapeutics, Inc. for $330.00 per share in cash for a total equity value of $14 billion in a move to strengthen its neuroscience portfolio.

In this article: BMY, KRTX Also: MRTX, ABBV

Read

Premarket Moves: Nike Dips 11%, Karuna Therapeutics Soars 48%

Article By: The Tokenist

Friday, December 22, 2023 9:11 AM EDT

Friday has seen several stocks make notable moves ahead of the market opening, with Nike (NKE) and Karuna Therapeutics (KRTX) capturing the most attention.

In this article: NKE, KRTX

Read